ArticleFrontiers in oncology2022

Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage.

Fengjiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.